Does a patient with Addison’s disease need to stop (wash out) propranolol 40 mg before adrenal function testing?

Propranolol Does Not Require Washout Before Adrenal Function Testing in Addison's Disease

Propranolol 40 mg does not need to be discontinued before adrenal function testing in patients with suspected or confirmed Addison's disease. Beta-blockers like propranolol are not listed among medications that interfere with adrenal function testing or cortisol measurement in any of the major guidelines for primary adrenal insufficiency.

Diagnostic Testing Considerations

Medications That Actually Interfere with Testing

The consensus guidelines for diagnosing primary adrenal insufficiency specify certain medications that affect hydrocortisone metabolism and require consideration, but beta-blockers are notably absent from these lists 1:

• CYP3A4 inducers (anti-epileptics, rifampin, phenytoin, phenobarbital) increase cortisol clearance 1
• CYP3A4 inhibitors (antifungals, certain antiretrovirals) decrease cortisol clearance 1
• Etomidate directly suppresses adrenal function 1

Standard Diagnostic Approach

When primary adrenal insufficiency is suspected, the recommended diagnostic pathway does not include discontinuation of beta-blockers 2, 1:

• Morning cortisol <250 nmol/L with elevated ACTH is diagnostic in acute illness 1
• Corticotropin stimulation test (250 μg cosyntropin) with peak cortisol <500 nmol/L confirms diagnosis 1
• Testing should proceed immediately when clinically indicated, with treatment initiated before results if adrenal crisis is suspected 2

Why Propranolol Doesn't Interfere

Mechanism of Action

Propranolol works through beta-adrenergic receptor blockade, not through interference with the hypothalamic-pituitary-adrenal axis or cortisol synthesis 3. The drug:

• Does not affect cortisol production or metabolism directly 3
• Does not interfere with ACTH secretion or action
• Does not alter aldosterone synthesis pathways

Metabolic Pathways

While propranolol is extensively metabolized by the liver via CYP2D6, CYP1A2, and CYP2C19 3, it does not significantly interact with the enzymes responsible for cortisol metabolism or measurement. The drug interactions listed in the FDA label involve other cardiovascular and psychotropic medications, not adrenal steroids 3.

Clinical Caveats

Beta-Blockade Effects to Monitor

While propranolol doesn't require washout for testing, clinicians should be aware of its effects in patients with Addison's disease 3:

• Masks hypoglycemia symptoms (tachycardia, tremor) which can occur in adrenal crisis 3
• May blunt compensatory responses to hypotension during adrenal insufficiency 3
• Does not prevent adrenal crisis or alter glucocorticoid requirements

When to Consider Medication Review

The only scenario requiring medication adjustment relates to treatment of hypertension in established Addison's disease, not diagnostic testing 1:

• If hypertension develops during fludrocortisone replacement, reduce fludrocortisone dose first 1
• If blood pressure remains elevated, add vasodilators while continuing mineralocorticoid replacement 2
• Beta-blockers can be used for essential hypertension in PAI patients 1

Practical Recommendations

Proceed directly with adrenal function testing without stopping propranolol when Addison's disease is suspected based on 2, 1:

• Hyperpigmentation, fatigue, salt craving, orthostatic hypotension 4
• Hyponatremia, hyperkalemia, or unexplained hypotension 2
• History of other autoimmune diseases (thyroid, ovarian failure) 5, 6

Measure both morning cortisol AND ACTH simultaneously at initial evaluation, as normal cortisol with markedly elevated ACTH (>300 pg/mL) can indicate early Addison's disease even before cortisol becomes frankly low 7, 5. This approach identifies patients in the "evolution" phase of adrenal insufficiency who would be missed by cortisol-only screening 5.